Table 2

Baseline characteristics for patients with and without any osteoporotic fracture
Baseline characteristic With any fracture Without fracture p-value
(n = 145) (n = 8019) (log-rank test)
N (%) N (%)
Sex Male 55 (37.9) 5163 (64.4) <.001
Female 90 (62.1) 2854 (35.6
Age <65 yrs 23 (15.9) 4276 (53.3) <.001
> = 65 yrs 122 (84.1) 3743 (46.7)
Ethnicity Western European 105 (78.9) 3171 (42.3) <.001
Oriental 15 (11.3) 1898 (24.7)
South Asian 7 (5.3) 2046 (26.6)
Other 6 (4.5) 566 (7.4)
Oxford Handicap Score > = 3 35 (24.7) 1859 (23.8) 0.18
<3 107 (75.4) 5952 (76.2)
Smoking (ever) Yes 72 (49.7) 3947 (49.9) 0.43
No 73 (50.3) 3966 (50.1)
Alcohol (any) Yes 54 (37.2) 2269 (28.3) 0.20
No 91 (62.8) 5748 (71.7)
Diabetes Yes 24 (16.6) 1875 (23.7) 0.21
No 121 (83.5) 6047 (76.3)
Stroke Yes 28 (19.3) 1254 (15.8) 0.28
No 117 (80.7) 6664 (84.2)
Myocardial infarction Yes 15 (10.3) 583 (7.4) 0.33
No 130 (89.7) 7317 (92.6)
Hypertension Yes 105 (72.4) 5632 (71.1) 0.45
No 40 (27.6) 2285 (28.9)
Depression Yes 16 (16.0) 528 (7.4) 0.003
No 84 (84.0) 6650 (92.6)
Antidepressant medication Yes 24 (16.6) 536 (6.8) <.001
No 121 (83.5) 7332 (93.2)
Corticosteroid medication Yes 3 (2.1) 47 (0.6) 0.011
No 142 (97.9) 7972 (99.4)
Any Osteoporosis Medication * Yes 23 (15.9) 556 (6.9) <.001
No 122 (84.1) 7463 (93.1)
Homocysteine level at baseline † (n = 40) (n = 1165) 0.43
mean (SD) 14.2 (6.2) 14.3 (8.6)

* Including Calcium, Vitamin D, Bisphosphonates and Hormone replacement therapy;

† Not all participants had homocysteine levels measured at Baseline.

Gommans et al.

Gommans et al. BMC Geriatrics 2013 13:88   doi:10.1186/1471-2318-13-88

Open Data